By Lenny Rachitsky · lennysnewsletter.com · @lennysan on X · YouTube · LinkedIn
Suril Kantaria, co-founder and CEO of Savvy, recounts the arc of a fintech startup that let employees buy their own health insurance with payment cards, from early missteps to a 2022 acquisition by a market incumbent. He argues that founders often start with a solution rather than a specific problem, that VC money can distort timing and headcount decisions, and that stealth mode slows learning. The story also covers losing conviction in a regulation-driven market and the mechanics of selling a startup, including staying patient, pushing for decision makers, and running parallel acquisition tracks. The lessons are most useful to early-stage founders deciding when to raise, when to go public, and how to exit.
01Key takeaways
- Validate a specific, painful problem with unbiased customer interviews before building or pitching a solution.
- Raise capital only when your own conviction and product metrics justify it, not because peers or investors push you to.
- Build publicly early to gather market signal and inbound interest rather than hiding behind a perceived stealth advantage.
- Pre-product-market fit, aim for either strong market pull or clear no-demand signals; a flat middle ground is dangerous.
- Treat acquisitions as a sales pipeline: cultivate interested acquirers early, qualify quickly, reach decision makers, and keep deal momentum high.
02Key sections
- Find a problem, not an idea
- The founders built a vision for modern health payments before validating any real customer pain. Biased sales-pitch interviews gave false signal until an unbiased script revealed no demand for the original idea.
- VC funding as a double-edged drug
- Raising early under YC pressure and pandemic uncertainty pushed the team into a fixed path and hiring spree. The author argues that only product traction should justify spending more.
- Building in public over stealth
- Staying quiet delayed customer inbounds and market feedback, which the author estimates cost about six months. Visible building attracts useful signal and accelerates product-market fit.
- Riptide versus wave
- A pivot to a new regulation-driven market led to steady but flat sales and unprofitable manual workarounds for large customers. Those customers churned, showing they lacked a sharp enough problem.
- Losing conviction and selling the company
- After tepid growth, the team weighed shutting down, restarting, or selling, and chose a sale. They then describe tactics such as nurturing acquirer interest, building a funnel of around 50 targets, and driving a tight deal close during a market downturn.
03From the post
“1. How Figma builds product 2. How to determine your activation metric 3. Discussion: What book most helped you become a better product manager? Subscribe to get access to these posts, and every post. I first met in 2020 when I was starting my life as a solo paid-newsletter person and realized I needed to figure out health insurance. Fortunately, Substack just started offering a perk called Savvy—a monthly stipend alongside a neat tool that gave me easy access to health insurance plans. Suril was the co-founder and CEO at Savvy, which in the early days meant he was my insurance advisor, enrollment specialist, and customer support—basically my personal health insurance guru. He went on to scale Savvy to tens of millions of dollars in payment volume, and earlier this year, Savvy was acquired by the leading incumbent in the market. When I caught up with Suril, he shared his startup story with me, and I found it incredibly powerful and insightful. I asked if I could share it with my newsletter audience, and I’m excited to do so below.…”
04Frameworks mentioned
Summary and takeaways written by PM Atlas; quotes are short excerpts. © the original author.